News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Bioversys Announces Last Patient Last Visit in BV100 Phase 2 Clinical Trial in Ventilator Associated Bacterial Pneumonia (VABP) and Provides a Business Update
Wednesday, October 16, 2024BioVersys AG a multiasset clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious lifethreatening infections caused by multidrug resistant MDR bacteria announced today the completion o...
Fresenius and Cellular Origins announce development agreement for Cell and Gene Therapy Manufacturing
Wednesday, October 16, 2024Fresenius via its operating company Fresenius Kabi and Cellular Origins a TTP Company have entered an agreement to develop integration strategies for Fresenius Kabis portfolio of Cell Therapy Technologies within Cellular Origins Constellation automat...
Chiesi Group's new Biotech Center of Excellence brings the future of medicine to Parma, Italy
Tuesday, October 15, 2024Chiesi Group an international biopharmaceutical company focused on research celebrated the operational launch of its Biotech Center of Excellence This stateoftheart facility is dedicated to developing and producing monoclonal antibodies enzymes and o...
SystImmune, Inc. Announces FDA Clearance of IND Application for BL-M11D1 in Relapsed/Refractory Acute Myeloid Leukemia
Tuesday, October 15, 2024SystImmune Inc a clinicalstage biotechnology company announced that the US Food and Drug Administration FDA has cleared its Investigational New Drug IND application for BLMD an antibodydrug conjugate ADC binding CD a protein on myeloid cells The IND...
Akeso Secures $250 Million USD to Propel Global Expansion of Its Innovative Drug Pipeline
Monday, October 14, 2024Akeso Biopharma announced that it has successfully raised approximately million USD through a share placement This offering has earned notable recognition among international investment firms with the majority of our final subscribers being longterm...
Bayer submits application for third indication of darolutamide in the EU
Monday, October 14, 2024Bayer today announced the submission of an application to the European Medicines Agency EMA for the oral androgen receptor inhibitor ARi darolutamide Bayer is seeking approval for the use of darolutamide in combination with androgen deprivation thera...
Lundbeck to acquire Longboard Pharmaceuticals in a strategic deal, significantly enhancing its neuroscience pipeline
Monday, October 14, 2024H Lundbeck AS and Longboard Pharmaceuticals Inc today announced an agreement for Lundbeck to acquire Longboard Under the terms of the agreement Lundbeck will commence a tender offer for all outstanding shares of Longboard common stock whereby Longboa...
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site
Friday, October 11, 2024Clearmind Medicine Inc a clinicalstage biotech company focused on discovery and development of novel psychedelicderived therapeutics to solve major undertreated health problems today announced it has received Institutional Review Board
Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation
Thursday, October 10, 2024Pharming Group NV announces the start of a Phase II proof of concept clinical trial evaluating leniolisib in primary immunodeficiencies PIDs with immune dysregulation linked to altered PIK signaling in lymphocytes The clinical trial is open for enrol...
Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals
Wednesday, October 09, 2024Tonix Pharmaceuticals Holding Corp a fullyintegrated biopharmaceutical company with marketed products and a pipeline of development candidates today announced that it has entered into an AI and ML research collaboration with XChem Inc XChem a leader...
